“These results reflect our businesses delivering increased value at an accelerating pace to society and the millions of people we serve,” UnitedHealth Group CEO David S. Wichmann said in a press release.
Meanwhile, Johnson & Johnson said revenue in all three of its major businesses, including pharmaceuticals, consumer health and medical devices, were flat or positive, and its consumer business improved revenue by 6% year-over-year, its best result in two years.
“It was a strong quarter across all three of our segments of the business,” J&J’s chief financial officer Joe Wolk told CNBC.
“Pharmaceuticals, I just can’t say enough about that division for us,” Wolk added. “It continues to just generate new products in a profound way that’s transformational to the current state of care, and that’s led the growth of our company for many quarters now.”
For more information on the healthcare segment, visit our healthcare category.